Home
Shares
News Centre
F&O
Mutual Funds
IPO
Portfolio
Commodity
Loans
Financial Planning
Insurance
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Tax Corner
NRI Centre
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
Yes Bank
24.08
42.49
Tata Stl
136.20
30.33
Ong Corp
256.00
95.64
I T C Lt
438.65
28.62
Ntpc Ltd
319.00
89.15
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals
Pharmaceuticals - Formulations
BSE:
532296
NSE:
GLENMARK
Bloomberg:
GNP@IN
Reuters:
GLEN.BO
Market Lot: 1
Face Value: 1
ISIN Demat: INE935A01035
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
09-Feb-2022
Glenmark launches Nitric Oxide Nasal Spray in India
IRIS
17-Jan-2022
Glenmark Pharmaceuticals arm gets tentative approval for Regadenoson Injection
IRIS
11-Oct-2021
Glenmark launches Tavulus for COPD treatment in Spain
IRIS
30-Sep-2021
Glenmark receives marketing approval for Ryaltris in 13 countries across EU and UK
IRIS
21-Sep-2021
Glenmark Pharmaceuticals receives USFDA approval for Clindamycin Phosphate Foam
IRIS
27-Jul-2021
Glenmark Life Sciences IPO opens today
IRIS
25-Jun-2021
Glenmark Pharmaceutical receives ANDA approval for Nintedanib Capsules
IRIS
23-Jun-2021
Glenmark gets ANDA approval for inhalation product
IRIS
18-Jun-2021
Glenmark launches Tiogiva in UK for treatment of COPD
IRIS
04-Jun-2021
Glenmark Pharma receives ANDA approval for Theophylline ExtendedRelease Tablets
IRIS
01-Jun-2021
Glenmark Pharmaceuticals launches Rufinamide Tablets USP
IRIS
24-May-2021
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection
IRIS
24-Mar-2021
Glenmark gets ANDA approval for Chlorpromazine Hydrochloride Tablets
IRIS
23-Mar-2021
Glenmark gets ANDA approval for Diltiazem Hydrochloride Extended-Release Capsules
IRIS
22-Mar-2021
Glenmark, Bausch Health join hands to commercialize RYALTRIS nasal spray in Canada
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Wealth Tracker
|
Tax Corner
|
NRI Centre
|
Search in myiris
|
Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer